Evidence Hub

Linear Mucosal Defect in Nintedanib-associated Colitis: A Rare Case with Collagenous Colitis-like Features

Iwata K, Yamazaki K, Kushima R, Ozawa N, Yamashita K, Shimizu S, Shimizu M

Internal medicine (Tokyo, Japan), 2026

Abstract

A 70-year-old man with idiopathic pulmonary fibrosis undergoing nintedanib treatment for 2 years experienced worsening diarrhea, which prompted colonoscopy. An examination revealed a coarse mucosal appearance and erosion extending from the rectum to the ascending colon with linear mucosal defects in the sigmoid colon. Histopathological findings from the biopsies demonstrated features resembling those of collagenous colitis (CC). The diarrheal symptoms resolved rapidly after nintedanib withdrawal. The patient was subsequently diagnosed with nintedanib-associated, drug-induced colitis with CC-like features. Although linear mucosal defects linked to proton pump inhibitors, particularly lansoprazole, have been reported in CC, they have not been previously described in nintedanib-associated colitis.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free